Last Posted: Feb 07, 2020
- Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer
AW Kurian et al, JAMA Oncology, February 6, 2020 - Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers.
Petelin Lara et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jan - Multigene panel testing results in patients with multiple breast cancer primaries.
Corredor Jessica et al. The breast journal 2020 Jan - Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
de Ruijter Tim C et al. Breast cancer research : BCR 2020 Jan 22(1) 13 - The spectrum of mutations predisposing to familial breast cancer in Poland.
Cybulski Cezary et al. International journal of cancer 2019 145(12) 3311-3320 - Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S et al. Gynecologic oncology 2020 Jan - Referencing BRCA in hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty.
Waltz Margaret et al. Journal of genetic counseling 2020 Jan - Using Next generation Sequencing to Redefine BRCAness in Triple-Negative Breast Cancer.
Lin Po-Han et al. Cancer science 2020 Jan - Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat Nasim et al. Breast cancer research : BCR 2020 Jan 22(1) 8 - BRCA Research Update: Looking Back At 2019 And Plans For The Future
S Domcheck Besser Center webinar, February 20, 2020
.jpeg)
No hay comentarios:
Publicar un comentario